Marked hyperlipidemia and pancreatitis associated with oral contraceptive therapy.
D000208:Acute Disease; D000328:Adult; D002914:Chylomicrons / Q000097:blood; D003276:Contraceptives, Oral / Q000009:adverse effects*; D004116:Dimethisterone / Q000009:adverse effects; D004338:Drug Combinations; D004997:Ethinyl Estradiol / Q000009:adverse effects; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood / Q000139:chemically induced* / Q000150:complications / Q000235:genetics; D008297:Male; D008656:Mestranol / Q000009:adverse effects; D008875:Middle Aged; D009640:Norethindrone / Q000009:adverse effects; D010195:Pancreatitis / Q000139:chemically induced*; D014280:Triglycerides / Q000097:blood
D002914:Chylomicrons; D003276:Contraceptives, Oral; D004338:Drug Combinations; D014280:Triglycerides; D004997:Ethinyl Estradiol; D008656:Mestranol; D004116:Dimethisterone; D009640:Norethindrone